Global Urinary Tract Cancer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 116 pages | ID: G6DF9F16A59GEN
GlobalInfoResearch

Abstracts

One of the early symptoms of urinary tract cancer is the presence of blood in the urine, haematuria. As cited in WHO report urinary tract cancer was the ninth-most highly occurent cancer types in 2012 and have high reoccurrence rate as well.

SCOPE OF THE REPORT:

The major factors favoring the growth of the urinary tract cancer treatment market are increasing incidence of urinary tract cancer worldwide owing to rising sedentary lifestyle, geriatric population, rising smoking population and rigorous research activities towards developing urinary tract cancer therapeutics. Clinical trial review of the therapeutics to treat urinary tract cancer seems to provide a lucrative growth prospects for this market.
The global Urinary Tract Cancer market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Urinary Tract Cancer.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Urinary Tract Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Urinary Tract Cancer market by product type and applications/end industries.
Market Segment by Companies, this report covers

• Spectrum Pharmaceuticals Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Genzyme Corporation
• F. Hoffmann-La Roche
• Shionogi
• Kyowa Hakko Kirin
• Medical Enzymes AG
• IkerChem
• Amgen Inc

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Urothelial Carcinoma
• Squamous Cell Carcinoma
• Adenocarcinoma
• Others

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Research Centers
• Others

Contents

1 URINARY TRACT CANCER MARKET OVERVIEW

1.1 Product Overview and Scope of Urinary Tract Cancer
1.2 Classification of Urinary Tract Cancer by Types
  1.2.1 Global Urinary Tract Cancer Revenue Comparison by Types (2017-2023)
  1.2.2 Global Urinary Tract Cancer Revenue Market Share by Types in 2017
  1.2.3 Urothelial Carcinoma
  1.2.4 Squamous Cell Carcinoma
  1.2.5 Adenocarcinoma
  1.2.6 Others
1.3 Global Urinary Tract Cancer Market by Application
  1.3.1 Global Urinary Tract Cancer Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Research Centers
  1.3.5 Others
1.4 Global Urinary Tract Cancer Market by Regions
  1.4.1 Global Urinary Tract Cancer Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Urinary Tract Cancer Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Urinary Tract Cancer Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Urinary Tract Cancer Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Urinary Tract Cancer Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Urinary Tract Cancer Status and Prospect (2013-2023)
1.5 Global Market Size of Urinary Tract Cancer (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Spectrum Pharmaceuticals Boehringer Ingelheim GmbH
  2.1.1 Business Overview
  2.1.2 Urinary Tract Cancer Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Spectrum Pharmaceuticals Boehringer Ingelheim GmbH Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bristol-Myers Squibb Company
  2.2.1 Business Overview
  2.2.2 Urinary Tract Cancer Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Bristol-Myers Squibb Company Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.3 Genzyme Corporation
  2.3.1 Business Overview
  2.3.2 Urinary Tract Cancer Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Genzyme Corporation Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.4 F. Hoffmann-La Roche
  2.4.1 Business Overview
  2.4.2 Urinary Tract Cancer Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 F. Hoffmann-La Roche Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.5 Shionogi
  2.5.1 Business Overview
  2.5.2 Urinary Tract Cancer Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Shionogi Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.6 Kyowa Hakko Kirin
  2.6.1 Business Overview
  2.6.2 Urinary Tract Cancer Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Kyowa Hakko Kirin Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.7 Medical Enzymes AG
  2.7.1 Business Overview
  2.7.2 Urinary Tract Cancer Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Medical Enzymes AG Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.8 IkerChem
  2.8.1 Business Overview
  2.8.2 Urinary Tract Cancer Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 IkerChem Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.9 Amgen Inc
  2.9.1 Business Overview
  2.9.2 Urinary Tract Cancer Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Amgen Inc Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL URINARY TRACT CANCER MARKET COMPETITION, BY PLAYERS

3.1 Global Urinary Tract Cancer Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Urinary Tract Cancer Players Market Share
  3.2.2 Top 10 Urinary Tract Cancer Players Market Share
3.3 Market Competition Trend

4 GLOBAL URINARY TRACT CANCER MARKET SIZE BY REGIONS

4.1 Global Urinary Tract Cancer Revenue and Market Share by Regions
4.2 North America Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
4.3 Europe Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
4.5 South America Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Urinary Tract Cancer Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA URINARY TRACT CANCER REVENUE BY COUNTRIES

5.1 North America Urinary Tract Cancer Revenue by Countries (2013-2018)
5.2 USA Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
5.3 Canada Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
5.4 Mexico Urinary Tract Cancer Revenue and Growth Rate (2013-2018)

6 EUROPE URINARY TRACT CANCER REVENUE BY COUNTRIES

6.1 Europe Urinary Tract Cancer Revenue by Countries (2013-2018)
6.2 Germany Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
6.3 UK Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
6.4 France Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
6.5 Russia Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
6.6 Italy Urinary Tract Cancer Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC URINARY TRACT CANCER REVENUE BY COUNTRIES

7.1 Asia-Pacific Urinary Tract Cancer Revenue by Countries (2013-2018)
7.2 China Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
7.3 Japan Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
7.4 Korea Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
7.5 India Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Urinary Tract Cancer Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA URINARY TRACT CANCER REVENUE BY COUNTRIES

8.1 South America Urinary Tract Cancer Revenue by Countries (2013-2018)
8.2 Brazil Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
8.3 Argentina Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
8.4 Colombia Urinary Tract Cancer Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE URINARY TRACT CANCER BY COUNTRIES

9.1 Middle East and Africa Urinary Tract Cancer Revenue by Countries (2013-2018)
9.2 Saudi Arabia Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
9.3 UAE Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
9.4 Egypt Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
9.5 Nigeria Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
9.6 South Africa Urinary Tract Cancer Revenue and Growth Rate (2013-2018)

10 GLOBAL URINARY TRACT CANCER MARKET SEGMENT BY TYPE

10.1 Global Urinary Tract Cancer Revenue and Market Share by Type (2013-2018)
10.2 Global Urinary Tract Cancer Market Forecast by Type (2018-2023)
10.3 Urothelial Carcinoma Revenue Growth Rate (2013-2023)
10.4 Squamous Cell Carcinoma Revenue Growth Rate (2013-2023)
10.5 Adenocarcinoma Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)

11 GLOBAL URINARY TRACT CANCER MARKET SEGMENT BY APPLICATION

11.1 Global Urinary Tract Cancer Revenue Market Share by Application (2013-2018)
11.2 Urinary Tract Cancer Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Research Centers Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)

12 GLOBAL URINARY TRACT CANCER MARKET SIZE FORECAST (2018-2023)

12.1 Global Urinary Tract Cancer Market Size Forecast (2018-2023)
12.2 Global Urinary Tract Cancer Market Forecast by Regions (2018-2023)
12.3 North America Urinary Tract Cancer Revenue Market Forecast (2018-2023)
12.4 Europe Urinary Tract Cancer Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Urinary Tract Cancer Revenue Market Forecast (2018-2023)
12.6 South America Urinary Tract Cancer Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Urinary Tract Cancer Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Urinary Tract Cancer Picture
Table Product Specifications of Urinary Tract Cancer
Table Global Urinary Tract Cancer and Revenue (Million USD) Market Split by Product Type
Figure Global Urinary Tract Cancer Revenue Market Share by Types in 2017
Figure Urothelial Carcinoma Picture
Figure Squamous Cell Carcinoma Picture
Figure Adenocarcinoma Picture
Figure Others Picture
Table Global Urinary Tract Cancer Revenue (Million USD) by Application (2013-2023)
Figure Urinary Tract Cancer Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Research Centers Picture
Figure Others Picture
Table Global Market Urinary Tract Cancer Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Urinary Tract Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Urinary Tract Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Urinary Tract Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Urinary Tract Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Urinary Tract Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Urinary Tract Cancer Revenue (Million USD) and Growth Rate (2013-2023)
Table Spectrum Pharmaceuticals Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table Spectrum Pharmaceuticals Boehringer Ingelheim GmbH Urinary Tract Cancer Type and Applications
Table Spectrum Pharmaceuticals Boehringer Ingelheim GmbH Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Urinary Tract Cancer Type and Applications
Table Bristol-Myers Squibb Company Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Genzyme Corporation Basic Information, Manufacturing Base and Competitors
Table Genzyme Corporation Urinary Tract Cancer Type and Applications
Table Genzyme Corporation Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Urinary Tract Cancer Type and Applications
Table F. Hoffmann-La Roche Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Shionogi Basic Information, Manufacturing Base and Competitors
Table Shionogi Urinary Tract Cancer Type and Applications
Table Shionogi Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table Kyowa Hakko Kirin Urinary Tract Cancer Type and Applications
Table Kyowa Hakko Kirin Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Medical Enzymes AG Basic Information, Manufacturing Base and Competitors
Table Medical Enzymes AG Urinary Tract Cancer Type and Applications
Table Medical Enzymes AG Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table IkerChem Basic Information, Manufacturing Base and Competitors
Table IkerChem Urinary Tract Cancer Type and Applications
Table IkerChem Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Inc Basic Information, Manufacturing Base and Competitors
Table Amgen Inc Urinary Tract Cancer Type and Applications
Table Amgen Inc Urinary Tract Cancer Revenue, Gross Margin and Market Share (2016-2017)
Table Global Urinary Tract Cancer Revenue (Million USD) by Players (2013-2018)
Table Global Urinary Tract Cancer Revenue Share by Players (2013-2018)
Figure Global Urinary Tract Cancer Revenue Share by Players in 2016
Figure Global Urinary Tract Cancer Revenue Share by Players in 2017
Figure Global Top 5 Players Urinary Tract Cancer Revenue Market Share in 2017
Figure Global Top 10 Players Urinary Tract Cancer Revenue Market Share in 2017
Figure Global Urinary Tract Cancer Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Urinary Tract Cancer Revenue (Million USD) by Regions (2013-2018)
Table Global Urinary Tract Cancer Revenue Market Share by Regions (2013-2018)
Figure Global Urinary Tract Cancer Revenue Market Share by Regions (2013-2018)
Figure Global Urinary Tract Cancer Revenue Market Share by Regions in 2017
Figure North America Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Europe Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure South America Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Table North America Urinary Tract Cancer Revenue by Countries (2013-2018)
Table North America Urinary Tract Cancer Revenue Market Share by Countries (2013-2018)
Figure North America Urinary Tract Cancer Revenue Market Share by Countries (2013-2018)
Figure North America Urinary Tract Cancer Revenue Market Share by Countries in 2017
Figure USA Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Canada Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Mexico Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Table Europe Urinary Tract Cancer Revenue (Million USD) by Countries (2013-2018)
Figure Europe Urinary Tract Cancer Revenue Market Share by Countries (2013-2018)
Figure Europe Urinary Tract Cancer Revenue Market Share by Countries in 2017
Figure Germany Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure UK Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure France Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Russia Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Italy Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Urinary Tract Cancer Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Urinary Tract Cancer Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Urinary Tract Cancer Revenue Market Share by Countries in 2017
Figure China Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Japan Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Korea Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure India Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Table South America Urinary Tract Cancer Revenue by Countries (2013-2018)
Table South America Urinary Tract Cancer Revenue Market Share by Countries (2013-2018)
Figure South America Urinary Tract Cancer Revenue Market Share by Countries (2013-2018)
Figure South America Urinary Tract Cancer Revenue Market Share by Countries in 2017
Figure Brazil Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Argentina Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Colombia Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Urinary Tract Cancer Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Urinary Tract Cancer Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Urinary Tract Cancer Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Urinary Tract Cancer Revenue Market Share by Countries in 2017
Figure Saudi Arabia Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure UAE Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Egypt Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure Nigeria Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Figure South Africa Urinary Tract Cancer Revenue and Growth Rate (2013-2018)
Table Global Urinary Tract Cancer Revenue (Million USD) by Type (2013-2018)
Table Global Urinary Tract Cancer Revenue Share by Type (2013-2018)
Figure Global Urinary Tract Cancer Revenue Share by Type (2013-2018)
Figure Global Urinary Tract Cancer Revenue Share by Type in 2017
Table Global Urinary Tract Cancer Revenue Forecast by Type (2018-2023)
Figure Global Urinary Tract Cancer Market Share Forecast by Type (2018-2023)
Figure Global Urothelial Carcinoma Revenue Growth Rate (2013-2018)
Figure Global Squamous Cell Carcinoma Revenue Growth Rate (2013-2018)
Figure Global Adenocarcinoma Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Urinary Tract Cancer Revenue by Application (2013-2018)
Table Global Urinary Tract Cancer Revenue Share by Application (2013-2018)
Figure Global Urinary Tract Cancer Revenue Share by Application (2013-2018)
Figure Global Urinary Tract Cancer Revenue Share by Application in 2017
Table Global Urinary Tract Cancer Revenue Forecast by Application (2018-2023)
Figure Global Urinary Tract Cancer Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Research Centers Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Urinary Tract Cancer Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Urinary Tract Cancer Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Urinary Tract Cancer Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Urinary Tract Cancer Revenue Market Forecast (2018-2023)
Figure Europe Urinary Tract Cancer Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Urinary Tract Cancer Revenue Market Forecast (2018-2023)
Figure South America Urinary Tract Cancer Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Urinary Tract Cancer Revenue Market Forecast (2018-2023)